X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2%
Thu, 30 May

NOVARTIS has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

NOVARTIS Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m1,2531,3561,104-18.6%-11.9%
Other incomeRs m1,09611513417.1%-87.7%
TurnoverRs m2,3491,4711,238-15.8%-47.3%
ExpensesRs m1,4721,221905-25.9%-38.5%
Gross profitRs m-21913519947.1%
DepreciationRs m6109-4.2%42.2%
InterestRs m5100-100.0%-100.0%
Profit before taxRs m81924032435.0%-60.5%
TaxRs m55511112915.6%-76.8%
Profit after taxRs m26512919551.7%-26.2%
Gross profit margin%-17.510.018.0
Effective tax rate%67.746.439.7
Net profit margin%11.38.715.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 11.9% on a year-on-year (YoY) basis. The expenses were down by 38.5% YoY during the same period.
  • The company's operating profit declined by 190.7% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 18.0% in 4QFY19 as against 17.5% in 4QFY18.
  • Depreciation charges increased by 42.2% and finance costs declined by 100.0% YoY, respectively.
  • Other income declined by 87.7% YoY during the quarter.
  • Net profit for the quarter declined by 26.2% YoY. Net profit margins during the quarter increased from 11.3% in 4QFY18 to 15.8% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 18.6% on a quarter-on-quarter (QoQ) basis. The expenses were down by 25.9% QoQ during the same period.
  • The company's operating profit increased by 47.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 18.0% in 4QFY19 as against 10.0% in 3QFY18.
  • Net profit for the quarter increased by 51.7% QoQ, while net profit margins increased from 8.8% in 3QFY18 to 15.8% in 4QFY19.

To see how NOVARTIS has performed over the last eight quarters, please visit here.

NOVARTIS Share Price Performance

Over the last one year, NOVARTIS share price has moved up from Rs 664.2 to Rs 702.3, registering a Gain of Rs 38.2 or around 5.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,339.1 (up 0.2%). Over the last one year it has moved up from 13,111.9 to 13,339.1, a gain of 227 points (up 1.7%).

Overall, the S&P BSE SENSEX is up 13.6% over the year.

Current Valuations

At the current price of Rs 702.3, the price to earnings (P/E) ratio of NOVARTIS stands at 455.1 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 32.1 times.

Equitymaster requests your view! Post a comment on "NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2%". Click here!

  

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

This Smallcap Stock could be the next Page Industries(Profit Hunter)

Jul 2, 2019

The smallcap rebound is taking longer to play out...and that's good news as it gives you more of action time and opportunities to invest in.

The Indian Rating Agency Cleanup Has Begun and this Cheap Stock Could be the Best Bet(The 5 Minute Wrapup)

Jul 2, 2019

The last time this big rating agency was as cheap and out-of-favour as it is today, the stock had corrected by 40% in six months.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 15, 2019 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - SUN PHARMA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS